ovarian cancer
Showing NaN - NaN of 110
Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in
Recruiting
- Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
- +12 more
- ADCT-301
- Pembrolizumab
-
Palo Alto, California
- +9 more
Mar 24, 2022
Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)
Active, not recruiting
- Ovarian Cancer
- +9 more
-
Berlin, Germany
- +14 more
Mar 10, 2022
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Chemotherapy, Rucaparib)
Active, not recruiting
- Ovarian Cancer
- +3 more
-
Denver, Colorado
- +76 more
Feb 20, 2022
Ovarian Cancer Trial in United Kingdom (Olaparib, Cediranib, Paclitaxel)
Active, not recruiting
- Ovarian Cancer
- Olaparib
- +2 more
-
Belfast, County Antrim, United Kingdom
- +13 more
Feb 22, 2022
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer Trial in Worldwide (Tumor Debulking Surgery (surgery in
Completed
- Fallopian Tube Cancer
- +2 more
- Tumor Debulking Surgery (surgery in recurrent ovarian disease)
-
Graz, Austria
- +85 more
Jan 21, 2022
Maintenance Niraparib in Treatment of Ovarian CanceR
Recruiting
- Ovarian Cancer
- +2 more
- Niraparib
-
Bath, United Kingdom
- +14 more
Jan 5, 2022
Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer Trial in Worldwide (Rucaparib)
Enrolling by invitation
- Metastatic Castration-Resistant Prostate Cancer
- +5 more
-
Lakewood, Colorado
- +37 more
Jan 18, 2022
Ovarian Tumors, Tumors, Ovarian, Ovarian Cancer Trial in United Kingdom (Pazopanib, Fosbretabulin)
Terminated
- Ovarian Neoplasms
- +2 more
-
Bath, United Kingdom
- +9 more
May 13, 2021
Cancer Diagnosis and Treatment on Everyday Life
Active, not recruiting
- Breast Cancer Female
- +17 more
-
Aberystwyth, United Kingdom
- +110 more
Mar 16, 2021
Ovarian Cancer Trial in United Kingdom, United States (NUC-1031 500 mg, NUC-1031 750mg)
Terminated
- Ovarian Cancer
- NUC-1031 500 mg
- NUC-1031 750mg
-
Phoenix, Arizona
- +16 more
Feb 16, 2021
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)
Completed
- Ovarian Cancer
- +3 more
-
San Francisco, California
- +15 more
Jan 19, 2021
Ovarian Cancer Trial in Worldwide (PDS (Primary Debulkdung Surgery), 6 cycles of standard chemo, Timing of surgery after 3
Active, not recruiting
- Ovarian Cancer
- PDS (Primary Debulkdung Surgery)
- +4 more
-
New York, New York
- +19 more
Jan 12, 2021
Cancer, Ovarian Cancer Trial in Belgium, Netherlands, United Kingdom (CPC634 (CriPec® docetaxel))
Completed
- Cancer
- Ovarian Cancer
- CPC634 (CriPec® docetaxel)
-
Leuven, Belgium
- +7 more
Dec 24, 2020
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (EPO906 (Patupilone), doxorubicin)
Completed
- Ovarian Cancer
- +2 more
- EPO906 (Patupilone)
- doxorubicin
-
Anchorage, Alaska
- +148 more
Dec 11, 2020
Rectal Cancer, Ovarian Cancer, Endometrial Cancer Trial in London (Sonablate 500 (High Intensity Focused Ultrasound (HIFU)))
Withdrawn
- Rectal Cancer
- +4 more
- Sonablate 500 (High Intensity Focused Ultrasound (HIFU))
-
London, England, United KingdomImperial College Healthcare NHS Trust (Hammersmith Hospital)
Nov 18, 2020
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,
Completed
- Epithelial Ovarian Cancer
- +3 more
- Mirvetuximab soravtansine
- +3 more
-
Birmingham, Alabama
- +130 more
Sep 24, 2020
Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer Trial in Worldwide (carboplatin, cisplatin, paclitaxel)
Completed
- Fallopian Tube Cancer
- +3 more
- carboplatin
- +2 more
-
Springfield, Missouri
- +49 more
Mar 31, 2020
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer Trial in Canada (carboplatin, erlotinib HCl)
Completed
- Fallopian Tube Cancer
- +2 more
- carboplatin
- erlotinib hydrochloride
-
Calgary, Alberta, Canada
- +7 more
Apr 6, 2020
Ovarian Cancer Trial in Canada, United Kingdom, United States (ISIS 5132)
Completed
- Ovarian Cancer
- ISIS 5132
-
Duluth, Minnesota
- +65 more
Apr 2, 2020